Abk�rzung zur Hauptnavigation Abk�rzung zu den Newsmeldungen Abk�rzung zu den Topstories  
  Barrierefreiheit    Kontakt MedUni Wien    Intranet    MedUni Wien - Shop    Universitätsbibliothek    Universitätsklinikum AKH Wien  
 
ccc_logo_en.gif
 
AKH Wien
 
 
Hauptnavigation
  • Livestream 2021
  • Home
  • Über das CCC
    • Allgemeines
    • Leitung der Organisationseinheit
    • CCC-Office Team
    • Kliniken und Partner
    • Qualitätsmanagement
    • Kontakt
  • PatientInnen
    • Covid-19
    • Allgemeines
    • Cancer School
    • Terminvereinbarung
    • Pflegeambulanz
    • PatientInnenvertretung
    • Links
  • Klinischer Bereich
    • Allgemeines
    • CCC Tumorboards
  • Wissenschaft & Forschung
    • Young CCC
    • CCC-ExpertInnenvideos
    • CCC Forschungscluster
    • CCC Units
    • CCC Platforms
    • Translationale Forschung
    • CCC Best Paper Award
    • CCC-TRIO Symposium
    • Kontakt/Links
  • Lehre
    • CCC Cancer School
    • Vienna International Summer School on Clinical and Experimental Oncology - VSSO
    • CCC Excellence Lecture
    • Interdisziplinäre onkologische Ausbildung
    • Klinisch-Praktisches Jahr (KPJ)
    • PhD Programme
    • Postgraduelle Fort- und Weiterbildung
    • Information/Contact
 
 
Subnavigation
    Inhaltsbereich


    Zurück zur Übersicht
    Journal of tissue engineering and regenerative medicine. 2021 Dec 3. doi: 10.1002/term.3273
    Gelatin methacryloyl (GelMA) as environment for chondrocytes and cell delivery to superficial cartilage defects.
    Hölzl K1,  Fürsatz M2,  Göcerler H3,  Schädl B4,  Žigon-Branc S5,  Markovic M6,  Gahleitner C7,  Van Hoorick J8,  Van Vlierberghe S9,  Kleiner A10,  Baudis S11,  Andreas P12,  Redl H13,  Ovsianikov A14,  Nürnberger S15
    Author information
    1Institute of Materials Science and Technology, 3D Printing and Biofabrication Group, Technical University of Vienna (TU Wien), Austria.
    2Department of Orthopedics and Trauma-Surgery, Division of Trauma-Surgery, Medical University of Vienna, Austria.
    3AC2T research GmbH, Austria.
    4Ludwig Boltzmann Institute for Experimental and Clinical Traumatology in AUVA Trauma Research Center, Austria.
    5Institute of Materials Science and Technology, 3D Printing and Biofabrication Group, Technical University of Vienna (TU Wien), Austria.
    6Institute of Materials Science and Technology, 3D Printing and Biofabrication Group, Technical University of Vienna (TU Wien), Austria.
    7Department of Orthopedics and Trauma-Surgery, Division of Trauma-Surgery, Medical University of Vienna, Austria.
    8Centre of Macromolecular Chemistry, Polymer Chemistry and Biomaterials Group, Ghent University, Belgium.
    9Centre of Macromolecular Chemistry, Polymer Chemistry and Biomaterials Group, Ghent University, Belgium.
    10Department of Orthopedics and Trauma-Surgery, Division of Trauma-Surgery, Medical University of Vienna, Austria.
    11Institute of Applied Synthetic Chemistry, TU Wien, Austria.
    12AC2T research GmbH, Austria.
    13Ludwig Boltzmann Institute for Experimental and Clinical Traumatology in AUVA Trauma Research Center, Austria.
    14Institute of Materials Science and Technology, 3D Printing and Biofabrication Group, Technical University of Vienna (TU Wien), Austria.
    15Department of Orthopedics and Trauma-Surgery, Division of Trauma-Surgery, Medical University of Vienna, Austria.
    Abstract

    Cartilage damage typically starts at its surface, either due to wear or trauma. Treatment of these superficial defects is important in preventing degradation and osteoarthritis (OA). Biomaterials currently used for deep cartilage defects lack appropriate properties for this application. Therefore, we investigated photo-crosslinked methacrylamide-modified gelatin (gelMA) as a candidate for treatment of surface defects. It allows for liquid application, filling of surface defects and forming a protective layer after UV-crosslinking, thereby keeping therapeutic cells in place. GelMA and photo-initiator (Li-TPO) concentration were optimized for application as a carrier to create a favourable environment for human articular chondrocytes (hAC). Primary hAC were used in passages 3 and 5, encapsulated into two different gelMA concentrations (7.5 wt% (soft) and 10 wt% (stiff)) and cultivated for 3 weeks with TGF-β3 (0, 1 and 10 ng/mL). Higher TGF-β3 concentrations induced spherical cell morphology independent of gelMA stiffness, while low TGF-β3 concentrations only induced rounded morphology in stiff gelMA. Gene expression did not vary across gel stiffnesses. As a functional model gelMA was loaded with two different cell types (hAC and/or human adipose-derived stem cells (ASC/TERT1) and applied to human osteochondral osteoarthritic plugs. GelMA attached to the cartilage, smoothened the surface and retained cells in place. Resistance against shear forces was tested using a tribometer, simulating normal human gait and revealing maintained cell viability. In conclusion gelMA is a versatile, biocompatible material with good bonding capabilities to cartilage matrix, allowing sealing and smoothening of superficial cartilage defects while simultaneously delivering therapeutic cells for tissue regeneration. This article is protected by copyright. All rights reserved.


    This article is protected by copyright. All rights reserved.

    KEYWORDS: Biocompatible Materials, Cartilage, Chondrocytes, Gelatin, Hydrogel, Osteoarthritis, Stem Cells, methacrylamide

    Publikations ID: 34861104
    Quelle: öffnen
     
    Drucken
     
    ccc_logo_en.gif
    ccc_logo_en.gif
    ccc_logo_en.gif

    Schnellinfo

     
    -- Initiative Krebsforschung / Krebsforschungslauf

    -- Cancer Care
    -- Kliniken und Partner
    -- CCC Cancer School
    -- Young CCC
    -- CCC Tumorboards
    -- CCC Forschungscluster
    -- CCC Units
    -- CCC Platforms
    -- SOPs / Leitlinien
    -- Kontakt
    Zuklappen
     
    Ausklappen
     
     

    Featured

     
     
     
     
     
     
     
     
     
     
     
     
     
    21sextury.org fake hub hd sexy hub eroticax.org
    © MedUni Wien |
     Impressum | Nutzungsbedingungen | Kontakt